1
|
Bévier A, Novel-Catin E, Blond E, Pelletier S, Koppe L, Fouque D. Étude VITAFLUX : mesure de la perte en vitamines et oligo-élements en hémodiafiltration post-dilution. Nephrol Ther 2022. [DOI: 10.1016/j.nephro.2022.07.399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
2
|
Andrian T, Novel-Catin E, Triffault-Fillit C, Rabeyrin M, Barba C, Koppe L, Fouque D. Crescentic glomerulonephritis with ANTI-PR3 ANCA associated with Bartonella Henselae infective endocarditis. Clin Kidney J 2022; 15:1966-1968. [PMID: 36158150 PMCID: PMC9494545 DOI: 10.1093/ckj/sfac117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Indexed: 11/22/2022] Open
Affiliation(s)
- Titus Andrian
- Department of Nephrology Dialysis and Nutrition, Hôpital Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France
- Grigore T.Popa University of Medicine and Pharmacy, Iași, Romania
| | - Etienne Novel-Catin
- Department of Nephrology Dialysis and Nutrition, Hôpital Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France
| | | | - Maud Rabeyrin
- Department of Anatomopathology, Hospices Civils de Lyon, Pierre-Bénite, France
| | - Christophe Barba
- Department of Nephrology Dialysis and Nutrition, Hôpital Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France
| | - Laetitia Koppe
- Department of Nephrology Dialysis and Nutrition, Hôpital Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France
| | - Denis Fouque
- Department of Nephrology Dialysis and Nutrition, Hôpital Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France
| |
Collapse
|
3
|
Espi M, Teuma C, Novel-Catin E, Maillet D, Souquet PJ, Dalle S, Koppe L, Fouque D. Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study. Eur J Cancer 2021; 147:29-39. [PMID: 33607383 DOI: 10.1016/j.ejca.2021.01.005] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2020] [Revised: 01/08/2021] [Accepted: 01/12/2021] [Indexed: 12/13/2022]
Abstract
BACKGROUND/OBJECTIVES Acute Kidney Injury (AKI), induced by Checkpoint Inhibitors therapies (CPI-induced AKI), is an uncommon but severe Immune-Related Adverse Event (IRAE). The aim was to describe the epidemiology, risks factors, clinical, and laboratory characteristics of these renal adverse events (AEs) in a real-life cohort treatment. DESIGN/PARTICIPANTS Consecutive patients undergoing a checkpoint inhibitor (CPI) therapy at the Hôpital Lyon Sud from January 2015 to July 2017 were included. A systematic retrospective analysis of medical files was performed, monthly serum creatinine levels, associated treatments, and occurrence of other IRAEs data were collected. AKI episodes explained by classic AKI aetiologies (prerenal, obstructive, septic) were excluded from the analysis. RESULTS CPI-induced AKI incidence was 3.7% (13/352) and appeared to be time-dependent (7.7% (11/143) for patients with >3 months of CPI exposure), ranging from 1 to 16 months. All cases with available histology were acute tubulointerstitial nephritis (ATIN), with poor urinary sediment. The severity of AKI was mild (stage 1 in 50% of cases), with no need for renal-replacement therapy. Although CPI-induced AKI patients had more frequently other IRAEs (77% versus 39%), this was not associated with a greater risk of AKI. Pre-existing chronic kidney disease (defined as an estimated glomerular filtration rate (eGFR) <60 ml/min) was not associated with a greater risk of CPI-induced AKI. Treatments of CPI-induced AKI were heterogeneous, with discontinuation of CPIs, and inconstant systemic corticosteroid therapy. CONCLUSION The monitoring of renal function and early identification of AKI during CPIs treatment is essential. The optimal management of CPI-induced AKI remains unclear and requires a close collaboration between the oncology and nephrology departments. CLINICAL RELEVANCY STATEMENT Immune checkpoint inhibitors (CPIs) have dramatically improved patient outcomes in different malignant contexts such as melanoma, non-small cell lung cancers (NSCLC) and urologic cancers. Usually well-tolerated, CPIs are however associated with immune-related adverse events (IRAEs). Among them, acute kidney injury (AKI) is uncommon, and not well-described. Following the exponential increase in the prescription of CPIs, previously uncommon cases of IRAEs (such as AKI) have become common occurrence in referral centres. Data regarding the epidemiology, risk factors, or management of CPI-induced AKI are currently lacking or can be discordant. Data regarding CPI-induced AKI, in a large real-life cohort were reported herein.
Collapse
Affiliation(s)
- M Espi
- Service de Néphrologie, Hôpital Lyon Sud - Hospices Civils de Lyon, 69310, Pierre Bénite, France.
| | - C Teuma
- Service de Néphrologie, Hôpital Nord Ouest, 69400, Gleizé, France
| | - E Novel-Catin
- Service de Néphrologie, Hôpital Lyon Sud - Hospices Civils de Lyon, 69310, Pierre Bénite, France; ImmuCare (Immunology Cancer Research), Hospices Civils de Lyon, Lyon, France
| | - D Maillet
- Service D'Oncologie, Hôpital Lyon Sud - Hospices Civils de Lyon, 69310, Pierre Bénite, France; ImmuCare (Immunology Cancer Research), Hospices Civils de Lyon, Lyon, France
| | - P J Souquet
- Service de Pneumologie, Hôpital Lyon Sud - Hospices Civils de Lyon, 69310, Pierre Bénite, France; ImmuCare (Immunology Cancer Research), Hospices Civils de Lyon, Lyon, France
| | - S Dalle
- Service de Dermatologie, Hôpital Lyon Sud - Hospices Civils de Lyon, 69310, Pierre Bénite, France; ImmuCare (Immunology Cancer Research), Hospices Civils de Lyon, Lyon, France
| | - L Koppe
- Service de Néphrologie, Hôpital Lyon Sud - Hospices Civils de Lyon, 69310, Pierre Bénite, France; Univ. Lyon, CarMeN Lab, INSA-Lyon, INSERM U1060, INRA, Université Claude Bernard Lyon 1, F-69621, Villeurbanne, France; ImmuCare (Immunology Cancer Research), Hospices Civils de Lyon, Lyon, France
| | - D Fouque
- Service de Néphrologie, Hôpital Lyon Sud - Hospices Civils de Lyon, 69310, Pierre Bénite, France; ImmuCare (Immunology Cancer Research), Hospices Civils de Lyon, Lyon, France
| |
Collapse
|
4
|
Novel-Catin E, Pelletier S, Fouque D, Roux JP, Chapurlat R, D'Haese P, Behets G, Evenepoel P, Nickolas TL, Lafage-Proust MH. Quantitative histomorphometric analysis of halved iliac crest bone biopsies yield comparable ROD diagnosis as full 7.5mm wide samples. Bone 2020; 138:115460. [PMID: 32485361 DOI: 10.1016/j.bone.2020.115460] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/26/2020] [Revised: 05/27/2020] [Accepted: 05/27/2020] [Indexed: 01/01/2023]
Abstract
BACKGROUND AND OBJECTIVES Histomorphometric analysis of a transiliac bone biopsy is the gold standard for the diagnosis of renal osteodystrophy (ROD). This procedure is costly, invasive and usually performed with a trephine with an internal diameter of 7.5 mm. Our objective was to evaluate the accuracy of ROD diagnosis on halved histological bone sections to determine if they are comparable to the standard 7.5 mm samples. DESIGN We included 68 bone biopsies performed in CKD patients for diagnostic purposes with a 7.5 mm diameter trephine. Quantitative histomorphometric analysis of the whole bone samples was performed including assessment of bone mineralization, turnover and volume. Each histological section (representing the whole 7.5 mm diameter biopsy) was then divided lengthwise in two hemisections (representing the 3.5 mm diameter biopsy). Histomorphometric analysis was repeated this time on the two hemibiopsies for each sample, blinded from initial results. Diagnoses were classified as osteitis fibrosa, adynamic bone disease, mixed uremic bone disease, osteomalacia or other. Correlations between the whole sample and the hemibiopsies for each parameter were studied. Concordance between the various bone parameters and final ROD diagnosis obtained from the whole section versus the two hemi sections was evaluated. RESULTS Highly significant correlations were found between parameters measured on the whole section and the corresponding hemisections, with r coefficient of 0.98 for osteoid surface and thickness and bone formation rate, 0.97 for osteoclast surface, and 0.96 for bone volume (p < 0.001). Final diagnosis was in full accordance between the whole biopsy and the two corresponding hemi-biopsies in 91% of cases. CONCLUSIONS Accurate diagnosis of ROD type was obtained by evaluation of bone surface areas of 3 mm diameter. These data suggest that small invasive bone biopsies might provide accurate ROD diagnostics while decreasing both invasiveness and cost of the procedure.
Collapse
Affiliation(s)
- Etienne Novel-Catin
- INSERM U1059 and University Hospital, Saint-Etienne, France; Université de Lyon, Lyon, France; Department of Nephrology, University Hospital - Lyon Sud, France.
| | | | - Denis Fouque
- Université de Lyon, Lyon, France; Department of Nephrology, University Hospital - Lyon Sud, France.
| | - Jean-Paul Roux
- Université de Lyon, Lyon, France; INSERM UMR 1033, Lyon Cedex 08, France.
| | - Roland Chapurlat
- Université de Lyon, Lyon, France; INSERM UMR 1033, Lyon Cedex 08, France.
| | - Patrick D'Haese
- Laboratory of Pathophysiology, University of Antwerp, Wilrijk, Belgium.
| | - Geert Behets
- Laboratory of Pathophysiology, University of Antwerp, Wilrijk, Belgium.
| | - Peter Evenepoel
- KU Leuven, Department of Microbiology and Immunology, Laboratory of Nephrology, Belgium.
| | | | | |
Collapse
|
5
|
Nouvier M, Chalençon E, Novel-Catin E, Pelletier S, Hallonet P, Charre C, Koppe L, Fouque D. First viral replication of Covid-19 identified in the peritoneal dialysis fluid of a symptomatic patient. Bull Dial Domic 2020. [DOI: 10.25796/bdd.v3i1.54503] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
RETRACTED : the authors retracted see : https://bdd.rdplf.org/index.php/bdd/article/view/54713
The COVID-19 pandemic is characterized by a disease with mainly respiratory tropism and varying severity.
Viral excretion of COVID-19 has been described in both urine and stool with the risk of contamination by stool. No viral replication in the peritoneal dialysis fluid has been reported to date.
We report an observation demonstrating the presence of the virus in the peritoneal dialysis drainage fluid of a COVID-19 patient. This underlines the importance in COVID-19 patients of considering dialysis fluid as a possible source of contamination.
Collapse
|
6
|
Novel-Catin E, Pelletier S, Reynaud Q, Nove-Josserand R, Durupt S, Dubourg L, Durieu I, Fouque D. Aminoglycoside exposure and renal function before lung transplantation in adult cystic fibrosis patients. Nephrol Dial Transplant 2018; 34:118-122. [DOI: 10.1093/ndt/gfy084] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2018] [Accepted: 03/12/2018] [Indexed: 11/14/2022] Open
Affiliation(s)
- Etienne Novel-Catin
- Département de Néphrologie, Centre Hospitalier Lyon SUD, Hospices Civils de Lyon, Pierre Bénite, France
| | - Solenne Pelletier
- Département de Néphrologie, Centre Hospitalier Lyon SUD, Hospices Civils de Lyon, Pierre Bénite, France
| | - Quitterie Reynaud
- Centre de Ressource et de Compétences Mucoviscidose, Hospices Civils de Lyon, Pierre Bénite, France
- EA 7425 HESPER, Université de Lyon, Lyon, France
| | - Raphaele Nove-Josserand
- Centre de Ressource et de Compétences Mucoviscidose, Hospices Civils de Lyon, Pierre Bénite, France
| | - Stephane Durupt
- Centre de Ressource et de Compétences Mucoviscidose, Hospices Civils de Lyon, Pierre Bénite, France
| | - Laurence Dubourg
- Néphrologie, Dialyse, Hypertension et Exploration Fonctionnelle Rénale, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
| | - Isabelle Durieu
- Centre de Ressource et de Compétences Mucoviscidose, Hospices Civils de Lyon, Pierre Bénite, France
- EA 7425 HESPER, Université de Lyon, Lyon, France
| | - Denis Fouque
- Département de Néphrologie, Centre Hospitalier Lyon SUD, Hospices Civils de Lyon, Pierre Bénite, France
- Inserm Carmen, Université de Lyon, Lyon, France
| |
Collapse
|